Oxygen Biotherapeutics signs pact to sell Dermacyte products
Under the terms of the agreement, DSL has exclusive rights to sell and distribute Oxygen Biotherapeutics’ Dermacyte skin care products that it purchases throughout the European Union, Switzerland
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.